Clinical Trial Update: Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluated erlotinib in patients with head and neck cancer that could be removed by surgery. The study assesses safety and feasibility of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Head and Neck Cancer | EARLY_Phase 1 | Status: COMPLETED